US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Plus Therapeutics

Recent news which mentions Plus Therapeutics

Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
Tickers PSTV
Tags Market News Interview Benzinga All Access
From Benzinga
Plus Therapeutics – Precision Radiology Is Proving Highly Effective At Fighting Cancer
Tickers PSTV
Tags Benzinga All Access Interview Market News
From Benzinga
This Company Is Developing Novel Treatments For Difficult To Treat CNS Cancers
Tickers PSTV
Tags Penny Stocks PSTV General
From Benzinga
Plus Therapeutics Has Experienced A Year Of Significant Clinical Progress
Tags Market News Partner Content General
From Benzinga
Plus Therapeutics Update: ReSPECT™ Clinical Trials For Treatment Of Difficult-to-Treat Cancers Are Showing Positive Results
Tags Market News General Partner Content
From Benzinga
This Company Marks A Milestone In The March Against Cancer
Tickers PSTV
Tags Market News Partner Content Penny Stocks
From Benzinga
Killing Cancer: Meet This Innovative Biotech Player
Tickers PSTV
Tags Penny Stocks PSTV General
From Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Tickers FUSN LNTH NVS PNT
Tags LNTH Small Cap Partner Content
From Benzinga
Plus Therapeutics Announces Positive Interim Data in Clinical Trial for New Brain Cancer Treatment
Tickers PSTV
Tags General PSTV Penny Stocks
From Benzinga
Plus Therapeutics Says Its Radiation Technology is The Most Precise in Targeting and Killing Cancer Cells
Tickers PSTV
Tags Biotech Plus Therapeutics Benzinga
From Benzinga
This Company's Innovative Targeted Radiation Therapy Could Offer Potential Hope for Cancer Patients
Tickers AZN NVS PFE PSTV
Tags Market News Penny Stocks Plus Therapeutics
From Benzinga